Are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same?

被引:18
作者
Alizadeh, Zeinab [1 ]
Baradaran, Hamid Reza [1 ,2 ,3 ]
Kohansal, Karim [4 ]
Hadaegh, Farzad [4 ]
Azizi, Fereidoun [5 ]
Khalili, Davood [4 ,6 ]
机构
[1] Iran Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Tehran, Iran
[2] Univ Aberdeen, Inst Appl Hlth Sci, Sch Med Med Sci & Nutr, Ageing Clin & Expt Res Team, Aberdeen, Scotland
[3] Iran Univ Med Sci, Inst Endocrinol & Metab, Endocrine Res Ctr, Tehran, Iran
[4] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran
[5] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Res Ctr, Tehran, Iran
[6] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Dept Biostat & Epidemiol, Tehran, Iran
来源
FRONTIERS IN ENDOCRINOLOGY | 2022年 / 13卷
关键词
normoglycemia; pre-diabetes; type; 2; diabetes; Cardiometabolic disorders; progression; regression; NORMAL GLUCOSE REGULATION; FAMILY-HISTORY; RISK; NORMALIZATION; TOLERANCE; HEALTH; IMPACT;
D O I
10.3389/fendo.2022.1041808
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundWe aimed to determine the predictors of regression to normoglycemia and progression to diabetes among subjects with pre-diabetes in a single model concurrently. MethodsThe present study included 1329 participants aged 20 to 70 years with prediabetes from the population-based cohort of the Tehran Lipid and Glucose Study, with a 10-year follow-up. Glycemic status at follow-up was categorized as regression to normoglycemia: fasting plasma glucose [FPG] of <5.55 and 2h-plasma glucose [PG] of <7.77 mmol/L, and not taking antidiabetic medications. Glycemic status at follow-up was categorized as progression to diabetes: FPG >= 7 or 2h-PG of >= 11.1 mmol/L, or taking antidiabetic medications. Glycemic status determined whether the patients remained in prediabetes category (isolated impaired fasting glycaemia [iIFG] [(5.55 <= FPG<7 and 2h-PG<7.77 mmol/L); isolated impared glucose tolarence [iIGT] (7.77 <= 2h-PG<11.1 and FGP<5.55 mmol/L)]. With prediabetes as a reference, multinomial logistic regression was utilized to identify the determinants of glycemic changes. ResultsApproximately 40% of participants returned to normoglycemia (n = 578), and similar percentage of participants progressed to diabetes (n = 518). Based on the multivariable multinomial model, regression to normoglycemia was associated with age (relative risk ratio [RRR] = 0.97; 95% CI, 0.95-0.99), female sex (RRR = 1.72; 95% CI, 1.18-2.50), high education level of >= 12 years (RRR = 2.10; 95% CI, 1.19-3.70), and combined IFG/impaired glucose tolerance (IGT) versus IFG (RRR = 0.45; 95% CI, 0.29-0.70). The risk of progression to diabetes increased with body mass index (RRR = 1.10; 95% CI, 1.05-1.15), waist circumference (RRR = 0.97; 95% CI, 0.96-0.99), positive familial history of diabetes (RRR = 1.62; 95% CI, 1.07-2.45), and combined IFG/IGT versus IFG (RRR = 2.54; 95% CI, 1.71-3.77). ConclusionA small percentage of patients with prediabetes remain in this condition, but the majority go on to develop diabetes or regress to normoglycemia. Both directions had distinct predictors.
引用
收藏
页数:10
相关论文
共 27 条
[1]   Metabolic risk factors among prediabetic individuals and the trajectory toward the diabetes incidence [J].
Ahmadi, Nooshin ;
Valizadeh, Majid ;
Hadaegh, Farzad ;
Mahdavi, Maryam ;
Tasdighi, Erfan ;
Azizi, Fereidoun ;
Khalili, Davood .
JOURNAL OF DIABETES, 2021, 13 (11) :905-914
[2]   Factors determining normalization of glucose intolerance in middle-aged Swedish men and women: a 8-10-year follow-up [J].
Alvarsson, M. ;
Hilding, A. ;
Ostenson, C. -G. .
DIABETIC MEDICINE, 2009, 26 (04) :345-353
[3]   Incidence of Diabetes and Prediabetes and Predictors of Progression Among Asian Indians: 10-Year Follow-up of the Chennai Urban Rural Epidemiology Study (CURES) [J].
Anjana, Ranjit Mohan ;
Rani, Coimbatore Subramanian Shanthi ;
Deepa, Mohan ;
Pradeepa, Rajendra ;
Sudha, Vasudevan ;
Nair, Haridas Divya ;
Lakshmipriya, Nagarajan ;
Subhashini, Sivasankaran ;
Binu, Valsalakumari Sreekumarannair ;
Unnikrishnan, Ranjit ;
Mohan, Viswanathan .
DIABETES CARE, 2015, 38 (08) :1441-1448
[4]   Review of Rationale, Design, and Initial Findings: Tehran Lipid and Glucose Study [J].
Azizi, Fereidoun ;
Zadeh-Vakili, Azita ;
Takyar, Miralireza .
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2018, 16 (04)
[5]   Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II [J].
Azizi, Fereidoun ;
Ghanbarian, Arash ;
Momenan, Amir Abbas ;
Hadaegh, Farzad ;
Mirmiran, Parvin ;
Hedayati, Mehdi ;
Mehrabi, Yadollah ;
Zahedi-Asl, Saleh .
TRIALS, 2009, 10
[6]   Lifestyle and Progression to Type 2 Diabetes in a Cohort of Workers with Prediabetes [J].
Bennasar-Veny, Miquel ;
Fresneda, Sergio ;
Lopez-Gonzalez, Arturo ;
Busquets-Cortes, Carla ;
Aguilo, Antoni ;
Yanez, Aina M. .
NUTRIENTS, 2020, 12 (05)
[7]   Variation in the risk of progression between glycemic stages across different levels of body mass index: evidence from a United States electronic health records system [J].
Blume, Steven W. ;
Li, Qian ;
Huang, Joanna C. ;
Hammer, Mette ;
Graf, Thomas R. .
CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (01) :115-124
[8]   Aging and insulin secretion [J].
Chang, AM ;
Halter, JB .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 284 (01) :E7-E12
[9]   Dysglycaemia and Other Predictors for Progression or Regression from Impaired Fasting Glucose to Diabetes or Normoglycaemia [J].
de Abreu, L. ;
Holloway, Kara L. ;
Kotowicz, Mark A. ;
Pasco, Julie A. .
JOURNAL OF DIABETES RESEARCH, 2015, 2015
[10]   Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: A systematic overview and meta-analysis of prospective studies [J].
Gerstein, Hertzel C. ;
Santaguida, Pasqualina ;
Raina, Parminder ;
Morrison, Katherine M. ;
Balion, Cynthia ;
Hunt, Dereck ;
Yazdi, Hossein ;
Booker, Lynda .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 78 (03) :305-312